Financials
- Market Capitalization 3.1 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-20.4
ratio cours/chiffre d'affaires
184.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1682 | TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 71.76 USD | -0.22% | -1.54% | +23.98% | +8.63% | 3.15 B USD | ||
| 1689 | IMNM Immunome, Inc. - Common Stock | 27.57 USD | -4.50% | -4.07% | +19.87% | +189.91% | 3.13 B USD | ||
| 1703 | IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +7.90% | +34.46% | 3.07 B USD | ||
| 1704 | CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +4.99% | +43.61% | 3.07 B USD |